Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

Genetic Vaccines and Therapy

Volumn 9, Issue , 2011, Pages

  Muazzam, Ambreen G ^a   Qureshi, Saleem ^b   Mansoor, Atika ^a   Ali, Lubna ^a   Iqbal, Musarrat ^b   Siddiqi, Saima ^a   Khan, Khalid M ^c   Mazhar, Kehkashan ^a  

^a INSTITUTE OF BIOMEDICAL AND GENETIC ENGINEERING IBGE   (Pakistan)

^b KRL Hospital   (Pakistan)

^c PMAS ARID AGRICULTURE UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; PEGINTERFERON ALPHA; RIBAVIRIN; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OCCULT HEPATITIS C; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCRIPTION; TREATMENT OUTCOME; VIRAL CLEARANCE;

HEPATITIS C VIRUS;

EID: 80052598427     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-9-14     Document Type: Article

References (22)

1. Tram NQP, Tomasz MI. Occult hepatitis C virus persistence: Identification and characteristics. Medical laboratory observer 2006, 1-6.
2. Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 2005, 36:967-972.
3. Hadziyannis SJ, Sette H, Morgan TR, Diago M, Marcellin P, Ramadori G, et al. PEG interferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004, 140:346-355.
4. Backus LI, Boothroyd DB, Phillips BR, Mole LA. Predictors of response of US veterans to treatment for the hepatitis C virus. Hepatology 2007, 46:37-47.
5. Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodri{dotless}'guez-Iñ igo E, de Lucas S, et al. Occult Hepatitis C Virus Infection in Patients in Whom the Etiology of Persistently Abnormal Results of Liver-Function Tests Is Unknown. J Infec Dis 2004, 189:7-14.
6. Carreño V. Occult hepatitis C virus infection: a new form of hepatitis C. World J Gastroenterol 2006, 12:6922-6925.
7. Castillo I, Rodriguez-Inigo E, Bartolome J. Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 2005, 54:682-685. 10.1136/gut.2004.057281, 1774478, 15831916.
8. Lo'pez-Alcorocho JM, Rodriguez-Iñigo E, Castillo I, Castellanos ME, Pardo M, Bartolomé J, et al. The role of genomic and antigenomic HCV-RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy. Ailment Pharmacol and Ther 2007, 25:1193-1201.
9. Bare P. Hepatitis C virus and peripheral blood mononuclear cell reservoirs. World J Hepatol 2009, 1:67-71. 10.4254/wjh.v1.i1.67, 2999261, 21160967.
10. Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factors. World J Gastro 2009, 15:5647-5653.
11. Ali L, Mansoor A, Ahmad N, Siddiqi S, Mazhar K, Muazzam AG, Qamar R, Khan KM. Patient HLA-DRB1* and - DQB1* allele and haplotype association with hepatitis C viruspersistence and clearance. J Gen Virol 2010, 91:1931-1938. 10.1099/vir.0.018119-0, 20392899.
12. Butt S, Idrees M, Akbar H, Awan Z, Afzal S, Shahid M, et al. The changing epidemiology pattern and frequency distribution of hepatitis C virus in Pakistan. Infection, Genet and Evol 2010, 10:595-600.
13. Bartolome' J, Lo' P, Castillo I. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol 2007, 81:7710-7715. 10.1128/JVI.02750-06, 1933375, 17475654.
14. Pham TN, Mercer SE. Michalak Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles. J Viral Hepat 2009, 16:547-556. 10.1111/j.1365-2893.2009.01092.x, 19215578.
15. Pardo M, Lo'pez-Alcorocho JM, Rodri{dotless}'guez-Iñ igo E, Castillo I, Carreño V. Comparative study between occult hepatitis C virus infection and chronic hepatitis C. J Viral Hepat 2007, 14:36-40. 10.1111/j.1365-2893.2006.00783.x, 17212642.
16. Idrees M, Lal A, Malik FA, Hussain A, Rehman I, Akbar H, et al. Occult hepatitis C virus infection and associated predictive factors: The Pakistan experience. Infec, Genet and Evol 2011,
17. Gallegos-Orozco JF, Rakela J, Rosati MJ, Vargas HE, Balan V. Persistence of Hepatitis C Virus in Peripheral Blood Mononuclear Cells of Sustained Viral Responders to Pegylated Interferon and Ribavirin Therapy. Dig Dis and Sci 2008, 53:2564-2568.
18. Maylin S, Martinot-Peignoux M, Moucari R, Ripault MP, Cazals-Hatem D, Giuily N, et al. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology 2008, 135:821-829. 10.1053/j.gastro.2008.05.044, 18593587.
19. Nicot F, Kamar N, Mariamé B, Rostaing L, Pasquier C, Izopet J. No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients. Transplant International 2010, 23:594-601.
20. Halfon P, Bourlie`re M, Se`ne D, Saadoun D, Khiri H, Pe'naranda G, et al. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J Clin Microbiol 2006, 44:2507-2511. 10.1128/JCM.00163-06, 1489518, 16825372.
21. Pham TNQ, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Hepatitis C virus persistence after spontaneous or treatment induced resolution of hepatitis C. J Virol 2004, 78:5867-5874. 10.1128/JVI.78.11.5867-5874.2004, 415836, 15140984.
22. Bernardin F, Tobler L, Walsh I, Williams JD, Busch M, Delwart E. Clearance of Hepatitis C Virus RNA from the Peripheral Blood Mononuclear Cells of Blood Donors Who Spontaneously or Therapeutically Control Their Plasma Viremia. hepatology 2008, 47:5.